NT5C2 K359Q
|
Leukemia
|
NT5C2 K359Q
|
Leukemia
|
DR6MP Resistant: D – Preclinical
|
DR6MP Resistant: D – Preclinical
|
NT5C2 K359Q
|
Leukemia
|
NT5C2 K359Q
|
Leukemia
|
mizoribine Sensitive: D – Preclinical
|
mizoribine Sensitive: D – Preclinical
|